Hopes Dashed for Rare Bone Cancer Treatment

FRIDAY, Aug. 26, 2016 — Adding extra drugs to chemotherapy doesn’t benefit patients with a rare type of bone cancer, according to a new study.
Osteosarcoma is diagnosed in about 600 people in the United States each year, mostly teenagers. With…
Source: Topamax